We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Early Surgery Best for Mitral Valve Leaks

By HospiMedica International staff writers
Posted on 28 Aug 2013
Early surgical repair of severe mitral valve regurgitation from flail leaflets improves long-term outcomes, according to a new study.

Researchers at the Mayo Clinic (Rochester, MN, USA), the University of Bologna (Italy), and other institutions conducted a study involving 2,097 consecutive patients in the Mitral Regurgitation International Database (MIDA) registry with flail mitral valve regurgitation to establish the comparative effectiveness of nonsurgical observation and early surgery. More...
The patients received routine cardiac care at six tertiary centers between 1980 and 2004, with mean follow-up of 10.3 years, with the main outcome measure being the association between treatment strategy and survival, heart failure, and new-onset atrial fibrillation (AF).

The results showed that there was no significant difference in early mortality and new-onset heart failure rates between treatment strategies at three months. In contrast, long-term survival rates were higher for patients with early surgery. Long-term heart failure risk was also lower with early surgery. Reduction in late-onset AF was not observed. The study was published in the August 14, 2013, issue of the Journal of the American Medical Association (JAMA).

“Repair within three months of diagnosis in absence of traditional class I indications was associated with roughly half the mortality risk of watchful waiting, for 10-year survival rates of 86% versus 69%,” concluded lead author Rakesh Suri, MD, PhD, of the Mayo Clinic, and colleagues. “Those benefits held even in the absence of traditional class I triggers for surgery and didn't come with any extra risk of atrial fibrillation overall.”

Flail leaflet prolapse occurs when a leaflet tip turns outward, becoming concave toward the left atrium, causing the deterioration of the mitral valve. The severity of flail leaflet varies, ranging from tip eversion to chordal rupture. The term itself refers to the dissociation of leaflet and chordae tendineae, providing for unrestricted motion of the leaflet. Patients with flail leaflets have a higher prevalence of mitral regurgitation than those with the non-flail subtype.

Related Links:

Mayo Clinic
University of Bologna




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.